Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Elisabetta Cameroni and Davide Corti.
Elisabetta Cameroni
Connection Strength
1.836
Davide Corti
  1. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021 10; 598(7880):342-347.
    View in: PubMed
    Score: 0.241
  2. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020 07; 583(7815):290-295.
    View in: PubMed
    Score: 0.221
  3. A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential. Cell. 2017 Sep 21; 171(1):229-241.e15.
    View in: PubMed
    Score: 0.184
  4. Tackling influenza with broadly neutralizing antibodies. Curr Opin Virol. 2017 06; 24:60-69.
    View in: PubMed
    Score: 0.179
  5. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science. 2016 Aug 19; 353(6301):823-6.
    View in: PubMed
    Score: 0.169
  6. Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science. 2021 09 03; 373(6559):1109-1116.
    View in: PubMed
    Score: 0.060
  7. Broad sarbecovirus neutralization by a human monoclonal antibody. Nature. 2021 09; 597(7874):103-108.
    View in: PubMed
    Score: 0.060
  8. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature. 2021 09; 597(7874):97-102.
    View in: PubMed
    Score: 0.060
  9. SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern. Science. 2021 08 06; 373(6555):648-654.
    View in: PubMed
    Score: 0.060
  10. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. Cell Rep. 2021 06 29; 35(13):109292.
    View in: PubMed
    Score: 0.059
  11. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021 04 29; 184(9):2332-2347.e16.
    View in: PubMed
    Score: 0.058
  12. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature. 2021 05; 593(7857):136-141.
    View in: PubMed
    Score: 0.058
  13. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell. 2021 03 04; 184(5):1171-1187.e20.
    View in: PubMed
    Score: 0.058
  14. Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland. Lancet Reg Health Eur. 2021 Feb; 1:100013.
    View in: PubMed
    Score: 0.057
  15. Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion. Cell. 2020 Dec 10; 183(6):1732.
    View in: PubMed
    Score: 0.057
  16. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science. 2020 11 20; 370(6519):950-957.
    View in: PubMed
    Score: 0.057
  17. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology. Cell. 2020 11 12; 183(4):1024-1042.e21.
    View in: PubMed
    Score: 0.056
  18. Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion. Cell. 2019 02 21; 176(5):1026-1039.e15.
    View in: PubMed
    Score: 0.050
  19. Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae. Nat Commun. 2017 12 08; 8(1):1991.
    View in: PubMed
    Score: 0.047
  20. Anti-LPS antibodies protect against Klebsiella pneumoniae by empowering neutrophil-mediated clearance without neutralizing TLR4. JCI Insight. 2017 May 04; 2(9).
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.